This inventor holds 4 USPTO granted patents. Top assignees: Sanofi-Synthelabo, Sanofi, Sanofi-Aventis. Active years: 1998-2006.
Company Filing History:
2 out of 152 
1 out of 1,540 
1 out of 390 
Years Active: 1998-2006
Title: Bruno Franc: Innovator in Pharmaceutical Chemistry
Introduction
Bruno Franc is a notable inventor based in Saze, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of irbesartan, a medication used to treat cardiovascular diseases. With a total of 4 patents to his name, Franc's work has had a meaningful impact on the medical community.
Latest Patents
Bruno Franc's latest patents focus on innovative forms of irbesartan. One of his inventions is a novel crystalline form of irbesartan, which includes processes for obtaining this form and pharmaceutical compositions containing it. This invention aims to enhance the effectiveness of treatments for cardiovascular diseases. Another patent also revolves around a similar crystalline form of irbesartan, emphasizing methods for obtaining it and its applications in pharmaceutical compositions.
Career Highlights
Throughout his career, Bruno Franc has worked with prominent companies in the pharmaceutical industry, including Sanofi-Synthelabo and Sanofi-Aventis. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.
Collaborations
Bruno Franc has collaborated with several professionals in his field, including Christian Hoff and Olivier Monnier. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Bruno Franc's contributions to pharmaceutical chemistry, particularly through his patents on irbesartan, highlight his role as an innovator in the field. His work continues to influence the treatment of cardiovascular diseases, showcasing the importance of innovation in medicine.